(Q47960038)

7 February 2018

title

Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study (English)

1 reference

7 February 2018

1 reference

4

1 reference

7 February 2018

Lars Lind

series ordinal

2

object named as

Lars Lind

1 reference

7 February 2018

3

Johannes Hulthe

1 reference

7 February 2018

author name string

Jonas Hansson

series ordinal

1

1 reference

7 February 2018

publication date

1 June 2009

1 reference

7 February 2018

European Journal of Cardiovascular Prevention and Rehabilitation

published in

1 reference

7 February 2018

volume

16

1 reference

7 February 2018

issue

3

1 reference

7 February 2018

page(s)

297-303

1 reference

7 February 2018

Circulating biomarkers of extracellular matrix remodeling and risk of atherosclerotic events

cites work

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213108

Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213108

Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213108

Clinical and echocardiographic correlates of plasma procollagen type III amino-terminal peptide levels in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213108

TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213108

Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213108

Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213108

Serum levels of matrix metalloproteinases and tumor necrosis factor-alpha in patients with idiopathic dilated cardiomyopathy and effect of carvedilol on these levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213108

Blood pressure-independent relations of left ventricular geometry to the metabolic syndrome and insulin resistance: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213108

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213108

Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213108

Plasma storage at -80 degrees C does not protect matrix metalloproteinase-9 from degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213108

Plasma tissue inhibitor of metalloproteinase-1 levels are elevated in essential hypertension and related to left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E3283213108

10.1097/HJR.0B013E3283213108

21 January 2018

Identifiers

DOI

1 reference

7 February 2018

release_w2ccwu7lyfaangjec5r7jmoshm

Fatcat ID

0 references

1 reference

7 February 2018